Get started
Affimed N.V.Affimed N.V.Affimed N.V.

Affimed N.V.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AFMD chart


Full chart

AFMD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪58.17 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.78 USD
Net income (FY)
‪−114.53 M‬ USD
Revenue (FY)
‪8.95 M‬ USD
Shares float
‪13.02 M‬
Beta (1Y)
2.17

Employees


Employees (FY)
78
Change (1Y)
−150 −65.79%
Revenue / Employee (1Y)
‪114.70 K‬ USD
Net income / Employee (1Y)
‪−1.47 M‬ USD

About Affimed N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Shawn M. Leland
Website
affimed.com
Headquarters
Mannheim
Founded
2000
ISIN
NL0015001ZQ0
FIGI
BBG006R5SSH5
Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AFMD news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AFMD is 3.76 USD — it has decreased by −0.78% in the past 24 hours. Watch Affimed N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Affimed N.V. stocks are traded under the ticker AFMD.
AFMD stock has risen by 17.90% compared to the previous week, the month change is a 27.33% rise, over the last year Affimed N.V. has showed a 15.76% increase.
We've gathered analysts' opinions on Affimed N.V. future price: according to them, AFMD price has a max estimate of 24.97 USD and a min estimate of 4.89 USD. Watch AFMD chart and read a more detailed Affimed N.V. stock forecast: see what analysts think of Affimed N.V. and suggest that you do with its stocks.
AFMD reached its all-time high on Jul 17, 2015 with the price of 242.00 USD, and its all-time low was 2.24 USD and was reached on Oct 27, 2023. View more price dynamics on AFMD chart.
See other stocks reaching their highest and lowest prices.
AFMD stock is 5.22% volatile and has beta coefficient of 2.17. Track Affimed N.V. stock price on the chart and check out the list of the most volatile stocks — is Affimed N.V. there?
Today Affimed N.V. has the market capitalization of ‪58.17 M‬, it has increased by 17.74% over the last week.
Yes, you can track Affimed N.V. financials in yearly and quarterly reports right on TradingView.
Affimed N.V. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
AFMD earnings for the last quarter are −1.08 USD per share, whereas the estimation was −1.04 USD resulting in a −4.22% surprise. The estimated earnings for the next quarter are −1.03 USD per share. See more details about Affimed N.V. earnings.
Affimed N.V. revenue for the last quarter amounts to ‪164.95 K‬ USD, despite the estimated figure of ‪1.16 M‬ USD. In the next quarter, revenue is expected to reach ‪1.67 M‬ USD.
AFMD net income for the last quarter is ‪−16.63 M‬ USD, while the quarter before that showed ‪−20.81 M‬ USD of net income which accounts for 20.08% change. Track more Affimed N.V. financial stats to get the full picture.
No, AFMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 78.00 employees. See our rating of the largest employees — is Affimed N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Affimed N.V. EBITDA is ‪−87.56 M‬ USD, and current EBITDA margin is ‪−1.32 K‬%. See more stats in Affimed N.V. financial statements.
Like other stocks, AFMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Affimed N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Affimed N.V. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Affimed N.V. stock shows the sell signal. See more of Affimed N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.